(62 days)
No
The device description and performance studies focus on a physical, non-electronic device for managing urinary leakage. There is no mention of software, algorithms, or data processing that would indicate the use of AI/ML.
Yes
The device is indicated for the management of urinary leakage in women suffering from stress urinary incontinence (SUI), which signifies a therapeutic purpose.
No
The device is indicated for the management of urinary leakage and is described as an external continence device that supports muscles to prevent urine loss, rather than diagnosing a condition.
No
The device description explicitly states it is a "small, flexible, cylindrical, non-sterile device... manufactured from soft silicone material," indicating it is a physical hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Description: The INSIGHT Medical FemAssist™ Flexible is an external device that is placed over the urethral opening. It does not analyze samples taken from the body.
- Intended Use: The intended use is for the management of urinary leakage by physically supporting and reinforcing the muscles controlling urine output. This is a mechanical function, not a diagnostic test.
Therefore, the device described is a medical device, but not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The FemAssist™ Flexible is an external female continence device indicated for the management of urinary leakage in women suffering from stress urinary incontinence (SUI).
Product codes
78MNG
Device Description
The INSIGHT Medical FemAssist™ device consists of a small, flexible, cylindrical, non-sterile device with a short profile which is manufactured from soft silicone material. The FemAssist™ fits over the external female urethral opening, between the labia, posterior to the clitoris and anterior to the vagina. The FemAssist™ is placed directly over the urettral opening where it is held in place by its own mild vacuum action, supporting and reinforcing the natural action of the muscles that control wine output and preventing accidental urine loss. Aquaphor oinment is applied to the device flange area prior to placing it over the urethral opening to help achieve a good seal. The flange area of the FemAssist™ Flexible device is thimer than that of the standard FemAssist™ cleared in K963858 for increased patient comfort.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Female urethral opening
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Market evaluation testing was performed at the Peakhurst community Health Centre, Peakhurst, New South Wales. Australia in early 1997. A total of 14 women evaluated the Flexible device.
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Study Type: Market evaluation testing
Sample Size: 14 women
Key Results: Of these 14, 4 patients withdrew from the study. Five of the 14 achieved a quantitative improvement as measured by a reduction in wine leakage during 1-hour pad weight testing. Two additional women reported that they liked the FemAssist™ Flexible device even though they did not achieve a quantitative improvement in the pad weight testing. The remaining patient, a very active athlete, found the Flexible device to be more comfortable than the "standard" FemAssist™, but did not feel that her leakage was well controlled while sprinting and cycling with either device. She did report success with the FemAssist™ while jogging. Subjective, non-quantitative data was presented for the remaining two reported that the FemAssist™ Flexible device was effective in controlling urine loss.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 876.5160 Urological clamp.
(a)
Identification. A urological clamp for males is a device used to close the urethra of a male to control urinary incontinence or to hold anesthetic or radiography contrast media in the urethra temporarily. It is an external clamp.(b)
Classification. Class I (general controls). Except when intended for internal use, the device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.
0
INSIGHT Medical Corp. 510(k) Premarket Notification December 10, 199
510(k) Summary
81092
FEB 12 1998
Pursuant to 512(i)(3)(A) of the Food, Drug and Cosmetic Act, INSIGHT Medical Corp. is required to submit with this Premarket Notification either an " ... adequate summary of any information respecting safety and effectiveness or state that information will be made available upon request of any person." INSIGHT Medical chooses to submit a summary of the safety and effectiveness information. The summary is as follows:
| Trade Name: | FemAssist™ Flexible |
|---|---|
| Owner/Operator: | INSIGHT Medical Corporation |
| 580 Main Street | |
| Bolton, MA 01740 | |
| Registration # 1221923 | |
| Device Generic Name: | Urethral clamp |
| Classification: | According to Section 513 of the Federal Food, Drug, and |
| Cosmetic Act, the device is considered "unclassified." Urethral clamps are | |
| addressed in 21 CFR 876.5160. The FemAssist™ product code is 78MNG. | |
| Predicate Device: | FemAssist™ |
| Manufactured and Distributed by: | |
| INSIGHT Medical Corp. | |
| 580 Main Street | |
| Bolton, MA 01740 | |
| K963858 |
Product Description:
The INSIGHT Medical FemAssist™ device consists of a small, flexible, cylindrical, non-sterile device with a short profile which is manufactured from soft silicone material. The FemAssist™ fits over the external female urethral opening, between the labia, posterior to the clitoris and anterior to the vagina. The FemAssist™ is placed directly over the urettral opening where it is held in place by its own mild vacuum action, supporting and reinforcing the natural action of the muscles that control wine output and preventing accidental urine loss. Aquaphor oinment is applied to the device flange area prior to placing it over the urethral opening to help achieve a good seal. The flange area of the FemAssist™ Flexible device is thimer than that of the standard FemAssist™ cleared in K963858 for increased patient comfort.
Indications for Use:
The FemAssist™ Flexible is an external female continence device indicated for the management of urinary leakage in women suffering from stress urinary incontinence (SUI).
Blocompatibility:
The FemAssist™ Flexible device will be manufactured from materials identical to those used in the FemAssist™ standard device; therefore, no biocompatibility testing was performed in support of this submission.
1
Safety and Performance:
The following safety and performance tests were performed on the FemAssist™ Flexible:
-
- Tensile test
- Pull-off Test 2.
- Lift-off Pressure Test 3.
The results of this testing demonstrated that the physical characteristics of the modified FemAssist™ device are equivalent to those of the currently marketed FemAssist™.
Clinical Testing:
Market evaluation testing was performed at the Peakhurst community Health Centre, Peakhurst, New South Wales. Australia in early 1997. A total of 14 women evaluated the Flexible device. Of these 14, 4 patients withdrew from the study. Five of the 14 achieved a quantitative improvement as measured by a reduction in wine leakage during 1-hour pad weight testing. Two additional women reported that they liked the FemAssist™ Flexible device even though they did not achieve a quantitative improvement in the pad weight testing. The remaining patient, a very active athlete, found the Flexible device to be more comfortable than the "standard" FemAssist™, but did not feel that her leakage was well controlled while sprinting and cycling with either device. She did report success with the FemAssist™ while jogging. Subjective, non-quantitative data was presented for the remaining two reported that the FemAssist™ Flexible device was effective in controlling urine loss.
Conclusion:
Based on the indications for use, technological characteristics and performance testing, the INSIGHT Medical FemAssist™ Flexible has been shown to be safe and effective for its intended use.
048
2
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room W-O66-0609 Silver Spring, MD 20993-0002
APR 2 6 2010
INSIGHT Medical Mr. Michael Vergano Director of Product Development/Operations 580 Main Street BOLTON MA 01740
Re: K974645
Trade/Device Name: FemAssistTMFlexible Continence Device Regulation Number: 21 CFR& 876.5160 Regulation Name: Urological clamp for males Regulatory Class: I Product Code: MNG Dated: December 10, 1997 Received: December 12, 1997
Dear Mr. Michael Vergano:
This letter corrects our substantially equivalent letter of February 12, 1998.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 Mr. Michael Vergano K974645
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to
http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safetv/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Janine M. Morris
Acting Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Page __ 1__ of ___ 1
510(k) Number (if known): ____________________________________________________________________________________________________________________________________________________
Device Name: _ INSIGHT Medical FemAssist™ Flexible
Indications for Use:
The INSIGHT Medical FemAssist™ Flexible is an external female continence The INSTOFT Medical For the nanagement of urinary leakage in women suffering from stress urinary incontinence (SUI).
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Robert R. Stirling
(Division Sign-Off) Division of Reproductive, Abdominat EN !... ------and Radiological Devices
510(k) Number K974641
Prescription Use V (Per 21 CFR 801.109) OR
Over-the -Counter Use _
001
C